Oct 2026
Real-World Outcomes of First-Line Nivolumab Monotherapy in Unfavorable Carcinoma of Unknown Primary: A Single-Center Retrospective Study
T. Sagawa, Shutaro Oiwa, S. Minobe et al.
· Journal of Gastrointestinal... · 0 citations